CLINICAL UPDATE: Selected Issues in Psychiatry

This CLINICAL UPDATE is supported by an educational grant from UCB Pharma, Inc., and is a supplement to Clinical Psychiatry News.
This supplement is based on a faculty interview and poster reviews.

•Faculty
•Topics

Click Here To view the supplement.

Faculty

Joseph F. Goldberg, MD
Director of Bipolar Disorders Research
The Zucker Hillside Hospital-North Shore Long Island Jewish Health System
Glen Oaks, N.Y.
Received Funding for Clinical Grants/Consultant: Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, and GlaxoSmithKline. He discusses the off-label use of levetiracetam for the treatment of psychiatric disorders.

Topics

• Anticonvulsants and Psychiatric Disorders

• Treatment of Varied Psychiatric Disorders in an Outpatient Setting

• Prevalence of ADHD in Adults

• Treatment of Mild or Moderate Bipolar Disorder

• Prevalence of Medical Comorbidity in Severe Psychiatric Disorders

• Evaluation of Therapy for Aggression Disorders

• Prevalence of Comorbid Anxiety Disorders

• Evaluation of Therapy for Bipolar Mania

• Evaluation of Add-On Therapy for Bipolar Disorder Therapy

Copyright © 2004 by International Medical News Group

This CLINICAL UPDATE is supported by an educational grant from UCB Pharma, Inc., and is a supplement to Clinical Psychiatry News.
This supplement is based on a faculty interview and poster reviews.

•Faculty
•Topics

Click Here To view the supplement.

Faculty

Joseph F. Goldberg, MD
Director of Bipolar Disorders Research
The Zucker Hillside Hospital-North Shore Long Island Jewish Health System
Glen Oaks, N.Y.
Received Funding for Clinical Grants/Consultant: Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, and GlaxoSmithKline. He discusses the off-label use of levetiracetam for the treatment of psychiatric disorders.

Topics

• Anticonvulsants and Psychiatric Disorders

• Treatment of Varied Psychiatric Disorders in an Outpatient Setting

• Prevalence of ADHD in Adults

• Treatment of Mild or Moderate Bipolar Disorder

• Prevalence of Medical Comorbidity in Severe Psychiatric Disorders

• Evaluation of Therapy for Aggression Disorders

• Prevalence of Comorbid Anxiety Disorders

• Evaluation of Therapy for Bipolar Mania

• Evaluation of Add-On Therapy for Bipolar Disorder Therapy

Copyright © 2004 by International Medical News Group

This CLINICAL UPDATE is supported by an educational grant from UCB Pharma, Inc., and is a supplement to Clinical Psychiatry News.
This supplement is based on a faculty interview and poster reviews.

•Faculty
•Topics

Click Here To view the supplement.

Faculty

Joseph F. Goldberg, MD
Director of Bipolar Disorders Research
The Zucker Hillside Hospital-North Shore Long Island Jewish Health System
Glen Oaks, N.Y.
Received Funding for Clinical Grants/Consultant: Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, and GlaxoSmithKline. He discusses the off-label use of levetiracetam for the treatment of psychiatric disorders.

Topics

• Anticonvulsants and Psychiatric Disorders

• Treatment of Varied Psychiatric Disorders in an Outpatient Setting

• Prevalence of ADHD in Adults

• Treatment of Mild or Moderate Bipolar Disorder

• Prevalence of Medical Comorbidity in Severe Psychiatric Disorders

• Evaluation of Therapy for Aggression Disorders

• Prevalence of Comorbid Anxiety Disorders

• Evaluation of Therapy for Bipolar Mania

• Evaluation of Add-On Therapy for Bipolar Disorder Therapy

Copyright © 2004 by International Medical News Group